In sensitivity analyses, we found that diabetes increased the risk of new‐onset CLD events by 4.8‐fold in APOB carriers, and this effect was further amplified by the presence of concurrent obesity. The gene discussed is APOB; the disease is obesity due to melanocortin 4 receptor deficiency.